日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers.

利用新型验证的组织生物标志物增强局部前列腺癌的风险分层模型

期刊:Prostate Cancer and Prostatic Diseases
影响因子:5.8
doi:10.1038/s41391-024-00918-9
Olah Csilla, Mairinger Fabian, Wessolly Michael, Joniau Steven, Spahn Martin, Kruithof-de Julio Marianna, Hadaschik Boris, Soós Aron, Nyirády Péter, Győrffy Balázs, Reis Henning, Szarvas Tibor
肿瘤
前列腺癌
发表日期：2025
文献求助 收藏

Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort

根治性前列腺切除术后pN1期前列腺癌的预后分层：来自多中心队列的竞争风险分析

期刊:European Urology Open Science
影响因子:4.5
doi:10.1016/j.euros.2025.07.008
Giesen, Alexander; Milonas, Daimantas; Laenen, Annouschka; Tosco, Lorenzo; Chlosta, Piotr; De Meerleer, Gert; Devos, Gaëtan; Everaerts, Wouter; Graefen, Markus; Gratzke, Christian; Marchioro, Giansilvio; Sanchez-Salas, Rafael; Tombal, Bertrand; Van Der Poel, Henk; Van Poppel, Hendrik; Venclovas, Zilvinas; Briganti, Alberto; Gontero, Paolo; Karnes, Jeffrey R; Spahn, Martin; Joniau, Steven
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Epiregulin expression and secretion is increased in castration-resistant prostate cancer

去势抵抗性前列腺癌中表皮调节素的表达和分泌增加

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1107021
Wiesehöfer, Marc; Raczinski, Benedikt Bernhard Gereon; Wiesehöfer, Caroline; Dankert, Jaroslaw Thomas; Czyrnik, Elena Dilara; Spahn, Martin; Kruithof-de Julio, Marianna; Wennemuth, Gunther
肿瘤
前列腺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Novel sequential treatment strategy for patients with muscle-invasive bladder cancer (MIBC): intravesical recombinant BCG, followed by neoadjuvant chemoimmunotherapy, radical cystectomy plus pelvic lymphadenectomy and adjuvant immunotherapy - protocol of a multicentre, single arm phase 2 trial (SAKK 06/19)

肌层浸润性膀胱癌 (MIBC) 患者的新型序贯治疗策略：膀胱内重组 BCG，随后进行新辅助化疗免疫疗法、根治性膀胱切除术加盆腔淋巴结清扫术和辅助免疫疗法——多中心、单臂 2 期试验方案 (SAKK 06/19)

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2022-067634
Petrausch, Ulf; Spahn, Martin; Schneider, Martina; Hayoz, Stefanie; Rentsch, Cyrill A; Rothschild, Sacha; Omlin, Aurelius; Cathomas, Richard
肿瘤
肿瘤免疫
膀胱癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort

Ki-67、拓扑异构酶IIα和miR-221在中期随访中对前列腺癌风险分层的能力有限：一项高危根治性前列腺切除术队列研究的结果

期刊:Translational Andrology and Urology
影响因子:1.7
doi:10.21037/tau-21-628
Marra, Giancarlo; Oderda, Marco; Calleris, Giorgio; Marquis, Alessandro; Peretti, Federica; Zitella, Andrea; Moschini, Marco; Sanchez-Salas, Rafael; Karnes, Robert Jeffrey; Kneitz, Burkhard; Spahn, Martin; Pacchioni, Donatella; Gontero, Paolo
Ki-67
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment

神经内分泌分化型前列腺癌细胞中AKT3表达增加会改变其对抗雄激素治疗的反应。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13030578
Wiesehöfer, Marc; Czyrnik, Elena Dilara; Spahn, Martin; Ting, Saskia; Reis, Henning; Dankert, Jaroslaw Thomas; Wennemuth, Gunther
肿瘤
AKT3
肿瘤免疫
前列腺癌
细胞生物学
AKT
免疫/内分泌
发表日期：2021
文献求助 收藏

Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer

患者性别与T1G3/HG膀胱癌膀胱内卡介苗免疫治疗后疗效的关系

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-021-03653-1
D'Andrea, David; Soria, Francesco; Grotenhuis, Anne J; Cha, Eugene K; Malats, Nuria; Di Stasi, Savino; Joniau, Steven; Cai, Tommaso; van Rhijn, Bas W G; Irani, Jaques; Karnes, Jeffrey; Varkarakis, John; Baniel, Jack; Palou, Joan; Babjuk, Marek; Spahn, Martin; Ardelt, Peter; Colombo, Renzo; Serretta, Vincenzo; Dalbagni, Guido; Gontero, Paolo; Bartoletti, Riccardo; Larré, Stephane; Malmstrom, Per-Uno; Sylvester, Richard; Shariat, Shahrokh F
肿瘤
肿瘤免疫
膀胱癌
免疫/内分泌
发表日期：2021
文献求助 收藏

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro

miR-221-3p调控高危前列腺癌中VEGFR2的表达，并代表了一种体外舒尼替尼耐药机制

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm9030670
Krebs, Markus; Solimando, Antonio Giovanni; Kalogirou, Charis; Marquardt, André; Frank, Torsten; Sokolakis, Ioannis; Hatzichristodoulou, Georgios; Kneitz, Susanne; Bargou, Ralf; Kübler, Hubert; Schilling, Bastian; Spahn, Martin; Kneitz, Burkhard
肿瘤
肿瘤免疫
信号转导
EGF
EGFR
VEGF
前列腺癌
发表日期：2020
文献求助 收藏

Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma

肾细胞癌根治性肾切除术和肿瘤血栓切除术后，采用器官移植为基础的治疗方法可显著降低术后并发症发生率。

期刊:Ejso
影响因子:2.9
doi:10.1016/j.ejso.2019.05.009
González, Javier; Gaynor, Jeffrey J; Martínez-Salamanca, Juan I; Capitanio, Umberto; Tilki, Derya; Carballido, Joaquín A; Chantada, Venancio; Daneshmand, Siamak; Evans, Christopher P; Gasch, Claudia; Gontero, Paolo; Haferkamp, Axel; Huang, William C; Espinós, Estefania Linares; Master, Viraj A; McKiernan, James M; Montorsi, Francesco; Pahernik, Sascha; Palou, Juan; Pruthi, Raj S; Rodriguez-Faba, Oscar; Russo, Paul; Scherr, Douglas S; Shariat, Shahrokh F; Spahn, Martin; Terrone, Carlo; Vera-Donoso, Cesar; Zigeuner, Richard; Hohenfellner, Markus; Libertino, John A; Ciancio, Gaetano
肿瘤
肿瘤免疫
肾癌
心血管
细胞生物学
发表日期：2019
文献求助 收藏

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics

将基于组织的基因组生物标志物纳入局部前列腺癌诊所

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-016-0613-7
Moschini, Marco; Spahn, Martin; Mattei, Agostino; Cheville, John; Karnes, R Jeffrey
肿瘤
前列腺癌
肿瘤免疫
发表日期：2016
文献求助 收藏